The Subcommittee on Economic and Consumer Policy sent letters to the CDC and FDA Oct. 5, requesting information and documents about control over public health messaging and agency actions.
“We are particularly concerned that a little-known office within the White House — the Office of Information and Regulatory Affairs — is exerting influence over what is supposed to be nonpartisan, scientific messaging,” subcommittee Chairman Raja Krishnamoorthi, D-Ill., wrote in letters to the CDC and FDA.
The Office of Information and Regulatory Affairs, part of the Office of Management and Budget, has power to review the actions of federal agencies.
In past testimony before Congress, CDC Director Robert Redfield, MD, and FDA Commissioner Stephen Hahn, MD, have both said their agencies have not been influenced by political pressure, according to CNBC.
More articles on leadership and management:
Baptist Health hospital cuts 36 jobs
Perspective: 6 trends likely to shape healthcare after COVID-19
Academic medical centers today and tomorrow: 5 key trends
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
